Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER2−/PIK3CA Wild-Type Advanced Breast Cancer

Journal of Clinical Oncology 2026

View at publisher
Authors: Sara A. Hurvitz, Rachel M. Layman, Giuseppe Curigliano, Fabrice André, Massimo Cristofanilli, Sung-Bae Kim, Jorge Luis Martínez Rodríguez, Jorge Carlos Nadal, Gun Min Kim, Louisa Lisa Lo, Yuly A. Remolina-Bonilla, Geronimo Rosselli
+15 more George Emile, Ernesto Korbenfeld, Juan Manuel Puig, Robert Wesolowski, Miguel Martin, Alistair Ring, Hyo Sook Han, Antonio Giordano, Sarah C. Mutka, Keren Moss, Sam Suzuki, Brian Sullivan, Igor Gorbatchevsky, Barbara Pistilli, for the VIKTORIA-1 Study Group
DOI: 10.1200/jco-26-01302
Cited by: 1

Fields of Study & Subjects

Advanced Breast Cancer Therapies PI3K/AKT/mTOR signaling in cancer HER2/EGFR in Cancer Research

Publication details

Journal / source
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Volume
44
Issue
19
Pages
1852–1852
Publication date
4 June 2026
Language
EN